CREST-2 (clinicaltrials.gov number: NCT02089217) is a pair of parallel, actively recruiting procedural trials to prevent stroke comparing: 1) carotid endarterectomy (CEA) and intensive medical ...
The results of the ongoing CREST-2 study in patients with asymptomatic, high-grade carotid artery stenosis are still several years away. But new data out of a companion registry suggest that whatever ...
Leading off his argument that CREST-2 is “a bad trial,” D. Christopher Metzger, MD, FSCAI, FACC, of Wellmont CVA Heart Institute, in Kingsport, Tenn., pointed out that results for CAS are improving ...
A low rate of periprocedural stroke/death with carotid stenting for both asymptomatic and symptomatic patients has been reported in a new registry study. The CREST-2 Registry study found that 30-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback